Literature DB >> 25729951

Construction and identification of recombinant adenovirus carrying human TIMP-1shRNA gene.

Y L Sun1, H Xie2, H L Lin1, Q Feng1, Y Liu1.   

Abstract

The aim of this study was to construct the recombinant adenovirus carrying human TIMP-1shRNA gene expression system for preliminary identification to lay the foundation for the further study of gene therapy. Using the Adeno-X system, the recombinant adenovirus plasmid pAdeno-X green fluorescent protein (GFP)-tissue inhibitor of metalloprotease (TIMP)-1 small hairpin (1shRNA) was constructed by including the target gene fragment of the TIMP-1shRNA shuttle plasmid pShuttle2-GFP-TIMP-1shRNA and the backbone plasmid pAdeno-X by homologous recombination in Escherichia coli. Recombinant plasmids were transfected into HEK293A cells to package the recombinant adenovirus rvAdeno-XGFP-TIMP-1shRNA. The recombinant adenovirus was identified by polymerase chain reaction, and the viral titer and infection efficiency were detected using GFP. Polymerase chain reaction and restriction endonuclease digestion demonstrated that rvAdeno-XGFP-TIMP-1shRNA had been successfully constructed, which has a strong ability to infect the kidney. The TIMP-1shRNA adenovirus expression vector was successfully constructed using homologous recombination methods.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25729951     DOI: 10.4238/2015.January.16.3

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  2 in total

1.  Do Surface Slope and Posture Influence Lower Extremity Joint Kinetics during Cycling?

Authors:  Yunqi Tang; Donghai Wang; Yong Wang; Keyi Yin; Cui Zhang; Limin Zou; Yu Liu
Journal:  Int J Environ Res Public Health       Date:  2020-04-21       Impact factor: 3.390

2.  The Immunotherapeutic Effect of SIRPα-Silenced DCs against Cervical Cancer.

Authors:  Xiaojie Li; Wenying Zhou; Yanlan Liang; Changzhi Xu; Zhizhi Xie; Jiayin Liang; Bo Hu
Journal:  J Immunol Res       Date:  2020-01-07       Impact factor: 4.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.